Ondansetron HCL 8 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FU9RK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,373
Award facts
- Contract value 100% obligated
- $14,373.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,373.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (500 count) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment of this order from its corporate office location in the same municipality.
This delivery order is one of numerous pharmaceutical procurement actions executed under AmerisourceBergen's comprehensive global prime vendor contract with the Defense Logistics Agency, which enables the supplier to furnish a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. Ondansetron, a generic antiemetic medication commonly used in military and veteran healthcare settings for nausea and vomiting management, exemplifies the routine pharmaceutical commodities distributed through this vehicle to the Defense Health Agency and related federal healthcare customers. The award reflects AmerisourceBergen's established capability to meet federal medical supply requirements at competitive pricing through its existing framework agreement with DLA.
Quick answers
Who was awarded contract SPE2DB25FU9RK?
SPE2DB25FU9RK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FU9RK worth?
The government has obligated $14,373 on SPE2DB25FU9RK.
Is contract SPE2DB25FU9RK an order under another contract?
Yes. SPE2DB25FU9RK is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9RK competed?
The extent of competition for SPE2DB25FU9RK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award